Effective treatment of secondary hyperparathyroidism in hemodialysis patients by titration of intravenous calcitriol dosage

Clinical Nephrology

Volumn 52, Issue 3, 1999, Pages 167-171

  Grekas, D ^a   Balaskas, E ^a   Kampouris, H ^a   Benos, A ^a   Konstantinou, A ^a   Sioulis, A ^a   Tourkantonis, A ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Hemodialysis; Hyperparathyroidism; Hyperphosphatemia; Intravenous calcitriol; Titration dosage

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM ION; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FOLLOW UP; HEMODIALYSIS PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; SECONDARY HYPERPARATHYROIDISM;

EID: 0032846860     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Andress DL, Norris KC, Coburn JW, Slatopolsky, E, Sherrad DJ 1989 Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failur. N Engl J Med 321: 274-279
2. 3 receptors are decreased in parathyroid glands from chronically uremic dogs. Kidney Int 35: 19-23
3. Canella G, Bonucci E. Rolla D, Ballanti P, Moriero E, Degrandi R, Augeri C, Claudiani F, DiMaio GD 1994 Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzed uremic patients treated with long-term intravenous calcitriol. Kidney Int 46: 1124-1132
4. Dressler R, Laut J, Lynn RI, GinsBerg N 1995 Long-term high dose intravenous calcitriol therapy in end-stage renal disease patients with severe secondary hyperparathyroidism. Clin Nephrol 43: 324-331
5. Fugawa M, Kaname S, Igarashi T, Ogata E, Kurokawa K 1991 Regulation of parathyroid hormone synthesis in chronic renal failure in rats. Kidney Int 39: 374-381
6. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92: 1436-1443
7. Llach F, Hervas J, Cerezo S 1995 The importance of dosing intravenous calcitriol in dialysis patients with severe hyperparathyroidism. Am J Kidney Dis 26: 845-851
8. 3. Nephron 58: 288-294
9. Quarles LD, Yohay DA, Caroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA 1994 Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45: 1710-1721
10. 3 in experimental renal hyperparathyroidism. Kidney Int 44: 1259-1265
11. Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F-1991 The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2: 1014-1020
12. Silver J, Naveh-Many T, Mayer H, Schmeizer HJ, Povtzer MM 1986 Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78: 1296-1301
13. Slatopolsky E, Weerts C, Thielan J, Horts R, Harter H, Martin KJ 1984 Marked suppression of secondary hyperparathyroidism by i.v. administration of 1,25 dihydroxycholecalciferol in uremic patients. J Clin Invest 74: 2136-2143
14. Sprague SM, Moe SM 1992 Safety and efficacy of longterm treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol. Am J Kidney Dis 19: 532-539